Carboplatin dosage: prospective evaluation of a simple formula based on renal function

Area of Science:

• Pharmacology
• Nephrology
• Oncology

Background:

• Carboplatin dosing is crucial for effective cancer chemotherapy.
• Individual patient factors, like kidney function, significantly impact drug clearance.
• Accurate prediction of carboplatin pharmacokinetics is essential for safe and effective treatment.

Purpose of the Study:

• To derive and validate a dosage formula for carboplatin.
• To correlate carboplatin plasma clearance with glomerular filtration rate (GFR).
• To establish target area under the curve (AUC) values for different patient groups.

Main Methods:

• Retrospective analysis of carboplatin pharmacokinetics in 18 patients.
• Prospective validation study in 31 patients with 40 carboplatin courses.
• Development and refinement of a dosage formula based on GFR and target AUC.

Main Results:

• Carboplatin plasma clearance showed a linear relationship with GFR (r=0.85, P<0.00001).
• The refined formula, Dose (mg) = target AUC x (GFR + 25), accurately predicted carboplatin exposure.
• Recommended target AUCs of 5 and 7 mg/mL/min for previously treated and untreated patients, respectively.

Conclusions:

• The GFR-based formula provides a simple, consistent method for adult carboplatin dosing.
• The formula is independent of toxicity, making it applicable to various chemotherapy regimens.
• Refined target AUCs ensure manageable hematological toxicity and optimize therapeutic outcomes.